![Mainz Biomed B.V. logo](/logos/MYNZ.webp)
Mainz Biomed B.V.
NASDAQ:MYNZ
Overview | Financials
Company Name | Mainz Biomed B.V. |
Symbol | MYNZ |
Currency | USD |
Price | 0.327 |
Market Cap | 7,145,967 |
Dividend Yield | 0% |
52-week-range | 0.306 - 4.38 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Guido Baechler |
Website | https://mainzbiomed.com |
An error occurred while fetching data.
About Mainz Biomed B.V.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD